Long-term safety and tolerability of remibrutinib (LOU064) in Phase 2b study in chronic spontaneous urticaria patientsA. Gimenez-Arnau, M. Maurer,M. Metz, V. Jain,P. Walsh,K. Lheritier, S. Hugot, H. Zouater,S. Haemmerle,A. ZharkovALLERGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
